Global Gene Therapy Market Report
Market Overview
Gene therapy involves the modification, replacement, or regulation of defective genes to treat or prevent diseases. It is applied through ex vivo (outside the body, then reintroduced) or in vivo (direct delivery into the patient) approaches. The technology is increasingly used in oncology, rare genetic disorders, cardiovascular diseases, and infectious diseases.
The global market is expected to grow significantly, driven by advances in vector technology, rising prevalence of genetic disorders, increasing investments in R&D, and regulatory approvals of novel therapies.
Key Market Players
Beyond the listed companies, several additional players contribute significantly to the global gene therapy market:
- Sangamo Therapeutics (U.S.)
- Spark Therapeutics (U.S.)
- Dimension Therapeutics (U.S.)
- Avalanche Biotechnologies (U.S.)
- Celladon Corporation (U.S.)
- Vical Incorporated (U.S.)
- Advantagene Inc. (U.S.)
- Bluebird Bio (U.S.)
- Novartis AG (Switzerland) – CAR-T and gene therapy portfolio.
- Gilead Sciences/Kite Pharma (U.S.) – oncology-focused gene therapies.
- Pfizer Inc. (U.S.) – expanding pipeline in rare diseases.
- Roche/Genentech (Switzerland/U.S.) – oncology and ophthalmology gene therapies.
- UniQure N.V. (Netherlands) – pioneering AAV-based therapies.
- REGENXBIO Inc. (U.S.) – AAV vector technology.
- Orchard Therapeutics (U.K.) – rare disease therapies.
- Editas Medicine (U.S.) – CRISPR-based gene editing.
- CRISPR Therapeutics (Switzerland) – gene editing for blood disorders.
- Intellia Therapeutics (U.S.) – in vivo CRISPR therapies.
- Beam Therapeutics (U.S.) – base editing technologies.
Segments Analysis
By Product Type
- Ex vivo Gene Therapy – cells modified outside the body and reintroduced.
- In vivo Gene Therapy – direct delivery of genetic material into the patient.
By Application
- Cancer Diseases – CAR-T therapies, tumor suppressor gene delivery.
- Monogenic Diseases – hemophilia, muscular dystrophy, cystic fibrosis.
- Infectious Diseases – HIV, hepatitis, emerging viral infections.
- Cardiovascular Diseases – ischemic heart disease, heart failure.
- Others – ophthalmology, neurology, metabolic disorders.
Regional Analysis – Highlights
- North America: Largest market; strong presence of biotech firms, advanced healthcare infrastructure, and FDA approvals.
- Europe: Germany, U.K., and France lead; EMA supports rare disease therapies.
- Asia-Pacific: China and Japan expanding R&D; India and South Korea emerging with clinical trials.
- Latin America: Brazil and Argentina show growing adoption in oncology and rare disease treatments.
- Middle East & Africa: Early-stage adoption; demand linked to healthcare modernization and rare disease initiatives.
Porter’s Five Forces
- Threat of New Entrants – Moderate (high R&D costs and regulatory hurdles, but growing biotech startups).
- Bargaining Power of Suppliers – Moderate (specialized vectors and raw materials impact costs).
- Bargaining Power of Buyers – High (patients, hospitals, and insurers demand affordability and efficacy).
- Threat of Substitutes – Moderate (cell therapies, RNA-based therapies, traditional pharmaceuticals).
- Industry Rivalry – High (intense competition among biotech firms and pharmaceutical giants).
SWOT Analysis
Strengths
- Potential for curative treatments.
- Strong pipeline of therapies across multiple indications.
- Increasing regulatory approvals.
Weaknesses
- High treatment costs limit accessibility.
- Complex manufacturing and logistics.
- Long regulatory timelines.
Opportunities
- Expansion into rare and orphan diseases.
- Growth in CRISPR and next-gen editing technologies.
- Rising investments in Asia-Pacific biotech hubs.
Threats
- Ethical and safety concerns.
- Competition from alternative therapies.
- Reimbursement challenges in developing markets.
Trend Analysis
- Rise of CRISPR and base editing technologies.
- Expansion of CAR-T and immuno-oncology applications.
- Growth in rare disease approvals and orphan drug incentives.
- Integration of AI in gene therapy R&D.
- Increasing partnerships between biotech startups and pharma giants.
Drivers & Challenges
Drivers
- Rising prevalence of genetic and rare diseases.
- Increasing regulatory approvals of novel therapies.
- Expanding investments in biotech R&D.
- Growing demand for personalized medicine.
Challenges
- High treatment costs and reimbursement barriers.
- Manufacturing complexity and scalability issues.
- Ethical concerns over genetic modification.
- Regulatory hurdles across different regions.
Value Chain Analysis
- Raw Materials – viral vectors, plasmids, CRISPR components.
- Production Technologies – ex vivo modification, in vivo delivery, vector engineering.
- Manufacturing & Processing – GMP facilities for gene therapy production.
- Distribution Channels – hospitals, specialty clinics, direct partnerships with healthcare providers.
- End-Use Industries – oncology, rare diseases, cardiovascular, infectious diseases.
Quick Recommendations for Stakeholders
- Manufacturers: Invest in scalable vector production and next-gen editing technologies.
- Investors: Focus on rare disease therapies and CRISPR-based startups.
- Governments & Regulators: Strengthen frameworks for approvals and reimbursement.
- Healthcare Providers: Expand infrastructure for advanced therapies.
- R&D Teams: Innovate delivery systems for in vivo therapies.
- Supply Chain Managers: Secure reliable sources of vectors and raw materials.
Table of Contents
Global Gene Therapy
1 Gene Therapy Market Overview
1.1 Product Overview and Scope of Gene Therapy
1.2 Classification of Gene Therapy by Product Category
1.2.1 Global Gene Therapy Market Size (Sales) Comparison by Type
1.2.2 Global Gene Therapy Market Size (Sales) Market Share by Type (Product Category) in
1.2.3 Ex vivo
1.2.4 In vivo
1.3 Global Gene Therapy Market by Application/End Users
1.3.1 Global Gene Therapy Sales (Volume) and Market Share Comparison by Application
1.3.1 Cancer Diseases
1.3.2 Monogenic Diseases
1.3.3 Infectious Diseases
1.3.4 Cardiovascular Diseases
1.3.5 Others
1.4 Global Gene Therapy Market by Region
1.4.1 Global Gene Therapy Market Size (Value) Comparison by Region
1.4.2 United States Gene Therapy Status and Prospect
1.4.3 Europe Gene Therapy Status and Prospect
1.4.4 China Gene Therapy Status and Prospect
1.4.5 Japan Gene Therapy Status and Prospect
1.4.6 Southeast Asia Gene Therapy Status and Prospect
1.4.7 India Gene Therapy Status and Prospect
1.5 Global Market Size (Value and Volume) of Gene Therapy
1.5.1 Global Gene Therapy Sales and Growth Rate
1.5.2 Global Gene Therapy Revenue and Growth Rate
2 Global Gene Therapy Competition by Players/Suppliers, Type and Application
2.1 Global Gene Therapy Market Competition by Players/Suppliers
2.1.1 Global Gene Therapy Sales and Market Share of Key Players/Suppliers
2.1.2 Global Gene Therapy Revenue and Share by Players/Suppliers
2.2 Global Gene Therapy (Volume and Value) by Type
2.2.1 Global Gene Therapy Sales and Market Share by Type
2.2.2 Global Gene Therapy Revenue and Market Share by Type
2.3 Global Gene Therapy (Volume and Value) by Region
2.3.1 Global Gene Therapy Sales and Market Share by Region
2.3.2 Global Gene Therapy Revenue and Market Share by Region
2.4 Global Gene Therapy (Volume) by Application
3 United States Gene Therapy (Volume, Value and Sales Price)
3.1 United States Gene Therapy Sales and Value
3.1.1 United States Gene Therapy Sales and Growth Rate
3.1.2 United States Gene Therapy Revenue and Growth Rate
3.1.3 United States Gene Therapy Sales Price Trend
3.2 United States Gene Therapy Sales Volume and Market Share by Players
3.3 United States Gene Therapy Sales Volume and Market Share by Type
3.4 United States Gene Therapy Sales Volume and Market Share by Application
4 Europe Gene Therapy (Volume, Value and Sales Price)
4.1 Europe Gene Therapy Sales and Value
4.1.1 Europe Gene Therapy Sales and Growth Rate
4.1.2 Europe Gene Therapy Revenue and Growth Rate
4.1.3 Europe Gene Therapy Sales Price Trend
4.2 Europe Gene Therapy Sales Volume and Market Share by Players
4.3 Europe Gene Therapy Sales Volume and Market Share by Type
4.4 Europe Gene Therapy Sales Volume and Market Share by Application
5 China Gene Therapy (Volume, Value and Sales Price)
5.1 China Gene Therapy Sales and Value
5.1.1 China Gene Therapy Sales and Growth Rate
5.1.2 China Gene Therapy Revenue and Growth Rate
5.1.3 China Gene Therapy Sales Price Trend
5.2 China Gene Therapy Sales Volume and Market Share by Players
5.3 China Gene Therapy Sales Volume and Market Share by Type
5.4 China Gene Therapy Sales Volume and Market Share by Application
6 Japan Gene Therapy (Volume, Value and Sales Price)
6.1 Japan Gene Therapy Sales and Value
6.1.1 Japan Gene Therapy Sales and Growth Rate
6.1.2 Japan Gene Therapy Revenue and Growth Rate
6.1.3 Japan Gene Therapy Sales Price Trend
6.2 Japan Gene Therapy Sales Volume and Market Share by Players
6.3 Japan Gene Therapy Sales Volume and Market Share by Type
6.4 Japan Gene Therapy Sales Volume and Market Share by Application
7 Southeast Asia Gene Therapy (Volume, Value and Sales Price)
7.1 Southeast Asia Gene Therapy Sales and Value
7.1.1 Southeast Asia Gene Therapy Sales and Growth Rate
7.1.2 Southeast Asia Gene Therapy Revenue and Growth Rate
7.1.3 Southeast Asia Gene Therapy Sales Price Trend
7.2 Southeast Asia Gene Therapy Sales Volume and Market Share by Players
7.3 Southeast Asia Gene Therapy Sales Volume and Market Share by Type
7.4 Southeast Asia Gene Therapy Sales Volume and Market Share by Application
8 India Gene Therapy (Volume, Value and Sales Price)
8.1 India Gene Therapy Sales and Value
8.1.1 India Gene Therapy Sales and Growth Rate
8.1.2 India Gene Therapy Revenue and Growth Rate
8.1.3 India Gene Therapy Sales Price Trend
8.2 India Gene Therapy Sales Volume and Market Share by Players
8.3 India Gene Therapy Sales Volume and Market Share by Type
8.4 India Gene Therapy Sales Volume and Market Share by Application
9 Global Gene Therapy Players/Suppliers Profiles and Sales Data
9.1 Sangamo
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Gene Therapy Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Sangamo Gene Therapy Sales, Revenue, Price and Gross Margin
9.1.4 Main Business/Business Overview
9.2 Spark Therapeutics
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Gene Therapy Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Spark Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin
9.2.4 Main Business/Business Overview
9.3 Dimension Therapeutics
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Gene Therapy Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Dimension Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin
9.3.4 Main Business/Business Overview
9.4 Avalanche Bio
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Gene Therapy Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Avalanche Bio Gene Therapy Sales, Revenue, Price and Gross Margin
9.4.4 Main Business/Business Overview
9.5 Celladon
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Gene Therapy Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Celladon Gene Therapy Sales, Revenue, Price and Gross Margin
9.5.4 Main Business/Business Overview
9.6 Vical
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Gene Therapy Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Vical Gene Therapy Sales, Revenue, Price and Gross Margin
9.6.4 Main Business/Business Overview
9.7 Advantagene
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Gene Therapy Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Advantagene Gene Therapy Sales, Revenue, Price and Gross Margin
9.7.4 Main Business/Business Overview
...
10 Gene Therapy Maufacturing Cost Analysis
10.1 Gene Therapy Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Gene Therapy
10.3 Manufacturing Process Analysis of Gene Therapy
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Gene Therapy Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Gene Therapy Major Manufacturers in
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Gene Therapy Market Forecast (2018-2025)
14.1 Global Gene Therapy Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Gene Therapy Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Gene Therapy Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Gene Therapy Price and Trend Forecast (2018-2025)
14.2 Global Gene Therapy Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Gene Therapy Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Gene Therapy Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Gene Therapy Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Gene Therapy Sales Forecast by Type (2018-2025)
14.3.2 Global Gene Therapy Revenue Forecast by Type (2018-2025)
14.3.3 Global Gene Therapy Price Forecast by Type (2018-2025)
14.4 Global Gene Therapy Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Gene Therapy
Figure Global Gene Therapy Sales Volume Comparison (K Units) by Type
Figure Global Gene Therapy Sales Volume Market Share by Type (Product Category) in
Figure Ex vivo Product Picture
Figure In vivo Product Picture
Figure Global Gene Therapy Sales Comparison (K Units) by Application
Figure Global Sales Market Share of Gene Therapy by Application in
Figure Cancer Diseases Examples
Table Key Downstream Customer in Cancer Diseases
Figure Monogenic Diseases Examples
Table Key Downstream Customer in Monogenic Diseases
Figure Infectious Diseases Examples
Table Key Downstream Customer in Infectious Diseases
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Gene Therapy Market Size (Million USD) by Regions
Figure United States Gene Therapy Revenue (Million USD) and Growth Rate
Figure Europe Gene Therapy Revenue (Million USD) and Growth Rate
Figure China Gene Therapy Revenue (Million USD) and Growth Rate
Figure Japan Gene Therapy Revenue (Million USD) and Growth Rate
Figure Southeast Asia Gene Therapy Revenue (Million USD) and Growth Rate
Figure India Gene Therapy Revenue (Million USD) and Growth Rate
Figure Global Gene Therapy Sales Volume (K Units) and Growth Rate
Figure Global Gene Therapy Revenue (Million USD) and Growth Rate
Figure Global Market Major Players Gene Therapy Sales Volume (K Units)
Table Global Gene Therapy Sales (K Units) of Key Players/Suppliers
Table Global Gene Therapy Sales Share by Players/Suppliers
Figure Gene Therapy Sales Share by Players/Suppliers
Figure Gene Therapy Sales Share by Players/Suppliers
Figure Global Gene Therapy Revenue (Million USD) by Players/Suppliers
Table Global Gene Therapy Revenue (Million USD) by Players/Suppliers
Table Global Gene Therapy Revenue Share by Players/Suppliers
Table Global Gene Therapy Revenue Share by Players
Table Global Gene Therapy Revenue Share by Players
Table Global Gene Therapy Sales (K Units) and Market Share by Type
Table Global Gene Therapy Sales Share (K Units) by Type
Figure Sales Market Share of Gene Therapy by Type
Figure Global Gene Therapy Sales Growth Rate by Type
Table Global Gene Therapy Revenue (Million USD) and Market Share by Type
Table Global Gene Therapy Revenue Share by Type
Figure Revenue Market Share of Gene Therapy by Type
Figure Global Gene Therapy Revenue Growth Rate by Type
Table Global Gene Therapy Sales Volume (K Units) and Market Share by Region
Table Global Gene Therapy Sales Share by Region
Figure Sales Market Share of Gene Therapy by Region
Figure Global Gene Therapy Sales Growth Rate by Region in
Table Global Gene Therapy Revenue (Million USD) and Market Share by Region
Table Global Gene Therapy Revenue Share (%) by Region
Figure Revenue Market Share of Gene Therapy by Region
Figure Global Gene Therapy Revenue Growth Rate by Region in
Table Global Gene Therapy Revenue (Million USD) and Market Share by Region
Table Global Gene Therapy Revenue Share (%) by Region
Figure Revenue Market Share of Gene Therapy by Region
Figure Global Gene Therapy Revenue Market Share by Region in
Table Global Gene Therapy Sales Volume (K Units) and Market Share by Application
Table Global Gene Therapy Sales Share (%) by Application
Figure Sales Market Share of Gene Therapy by Application
Figure Global Gene Therapy Sales Market Share by Application
Figure United States Gene Therapy Sales (K Units) and Growth Rate
Figure United States Gene Therapy Revenue (Million USD) and Growth Rate
Figure United States Gene Therapy Sales Price (USD/Unit) Trend
Table United States Gene Therapy Sales Volume (K Units) by Players
Table United States Gene Therapy Sales Volume Market Share by Players
Figure United States Gene Therapy Sales Volume Market Share by Players in
Table United States Gene Therapy Sales Volume (K Units) by Type
Table United States Gene Therapy Sales Volume Market Share by Type
Figure United States Gene Therapy Sales Volume Market Share by Type in
Table United States Gene Therapy Sales Volume (K Units) by Application
Table United States Gene Therapy Sales Volume Market Share by Application
Figure United States Gene Therapy Sales Volume Market Share by Application in
Figure Europe Gene Therapy Sales (K Units) and Growth Rate
Figure Europe Gene Therapy Revenue (Million USD) and Growth Rate
Figure Europe Gene Therapy Sales Price (USD/Unit) Trend
Table Europe Gene Therapy Sales Volume (K Units) by Players
Table Europe Gene Therapy Sales Volume Market Share by Players
Figure Europe Gene Therapy Sales Volume Market Share by Players in
Table Europe Gene Therapy Sales Volume (K Units) by Type
Table Europe Gene Therapy Sales Volume Market Share by Type
Figure Europe Gene Therapy Sales Volume Market Share by Type in
Table Europe Gene Therapy Sales Volume (K Units) by Application
Table Europe Gene Therapy Sales Volume Market Share by Application
Figure Europe Gene Therapy Sales Volume Market Share by Application in
Figure China Gene Therapy Sales (K Units) and Growth Rate
Figure China Gene Therapy Revenue (Million USD) and Growth Rate
Figure China Gene Therapy Sales Price (USD/Unit) Trend
Table China Gene Therapy Sales Volume (K Units) by Players
Table China Gene Therapy Sales Volume Market Share by Players
Figure China Gene Therapy Sales Volume Market Share by Players in
Table China Gene Therapy Sales Volume (K Units) by Type
Table China Gene Therapy Sales Volume Market Share by Type
Figure China Gene Therapy Sales Volume Market Share by Type in
Table China Gene Therapy Sales Volume (K Units) by Application
Table China Gene Therapy Sales Volume Market Share by Application
Figure China Gene Therapy Sales Volume Market Share by Application in
Figure Japan Gene Therapy Sales (K Units) and Growth Rate
Figure Japan Gene Therapy Revenue (Million USD) and Growth Rate
Figure Japan Gene Therapy Sales Price (USD/Unit) Trend
Table Japan Gene Therapy Sales Volume (K Units) by Players
Table Japan Gene Therapy Sales Volume Market Share by Players
Figure Japan Gene Therapy Sales Volume Market Share by Players in
Table Japan Gene Therapy Sales Volume (K Units) by Type
Table Japan Gene Therapy Sales Volume Market Share by Type
Figure Japan Gene Therapy Sales Volume Market Share by Type in
Table Japan Gene Therapy Sales Volume (K Units) by Application
Table Japan Gene Therapy Sales Volume Market Share by Application
Figure Japan Gene Therapy Sales Volume Market Share by Application in
Figure Southeast Asia Gene Therapy Sales (K Units) and Growth Rate
Figure Southeast Asia Gene Therapy Revenue (Million USD) and Growth Rate
Figure Southeast Asia Gene Therapy Sales Price (USD/Unit) Trend
Table Southeast Asia Gene Therapy Sales Volume (K Units) by Players
Table Southeast Asia Gene Therapy Sales Volume Market Share by Players
Figure Southeast Asia Gene Therapy Sales Volume Market Share by Players in
Table Southeast Asia Gene Therapy Sales Volume (K Units) by Type
Table Southeast Asia Gene Therapy Sales Volume Market Share by Type
Figure Southeast Asia Gene Therapy Sales Volume Market Share by Type in
Table Southeast Asia Gene Therapy Sales Volume (K Units) by Application
Table Southeast Asia Gene Therapy Sales Volume Market Share by Application
Figure Southeast Asia Gene Therapy Sales Volume Market Share by Application in
Figure India Gene Therapy Sales (K Units) and Growth Rate
Figure India Gene Therapy Revenue (Million USD) and Growth Rate
Figure India Gene Therapy Sales Price (USD/Unit) Trend
Table India Gene Therapy Sales Volume (K Units) by Players
Table India Gene Therapy Sales Volume Market Share by Players
Figure India Gene Therapy Sales Volume Market Share by Players in
Table India Gene Therapy Sales Volume (K Units) by Type
Table India Gene Therapy Sales Volume Market Share by Type
Figure India Gene Therapy Sales Volume Market Share by Type in
Table India Gene Therapy Sales Volume (K Units) by Application
Table India Gene Therapy Sales Volume Market Share by Application
Figure India Gene Therapy Sales Volume Market Share by Application in
Table Sangamo Basic Information List
Table Sangamo Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
Figure Sangamo Gene Therapy Sales Growth Rate
Figure Sangamo Gene Therapy Sales Global Market Share
Figure Sangamo Gene Therapy Revenue Global Market Share
Table Spark Therapeutics Basic Information List
Table Spark Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
Figure Spark Therapeutics Gene Therapy Sales Growth Rate
Figure Spark Therapeutics Gene Therapy Sales Global Market Share
Figure Spark Therapeutics Gene Therapy Revenue Global Market Share
Table Dimension Therapeutics Basic Information List
Table Dimension Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
Figure Dimension Therapeutics Gene Therapy Sales Growth Rate
Figure Dimension Therapeutics Gene Therapy Sales Global Market Share (2013-2018
Figure Dimension Therapeutics Gene Therapy Revenue Global Market Share
Table Avalanche Bio Basic Information List
Table Avalanche Bio Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
Figure Avalanche Bio Gene Therapy Sales Growth Rate
Figure Avalanche Bio Gene Therapy Sales Global Market Share
Figure Avalanche Bio Gene Therapy Revenue Global Market Share
Table Celladon Basic Information List
Table Celladon Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
Figure Celladon Gene Therapy Sales Growth Rate
Figure Celladon Gene Therapy Sales Global Market Share
Figure Celladon Gene Therapy Revenue Global Market Share
Table Vical Basic Information List
Table Vical Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
Figure Vical Gene Therapy Sales Growth Rate
Figure Vical Gene Therapy Sales Global Market Share (2013-2018
Figure Vical Gene Therapy Revenue Global Market Share
Table Advantagene Basic Information List
Table Advantagene Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
Figure Advantagene Gene Therapy Sales Growth Rate
Figure Advantagene Gene Therapy Sales Global Market Share
Figure Advantagene Gene Therapy Revenue Global Market Share
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gene Therapy
Figure Manufacturing Process Analysis of Gene Therapy
Figure Gene Therapy Industrial Chain Analysis
Table Raw Materials Sources of Gene Therapy Major Players in
Table Major Buyers of Gene Therapy
Table Distributors/Traders List
Figure Global Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Gene Therapy Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Gene Therapy Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Gene Therapy Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Gene Therapy Sales Volume Market Share Forecast by Regions in 2025
Table Global Gene Therapy Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Gene Therapy Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Gene Therapy Revenue Market Share Forecast by Regions in 2025
Figure United States Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Gene Therapy Revenue and Growth Rate Forecast (2018-2025)
Figure China Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Gene Therapy Sales (K Units) Forecast by Type (2018-2025)
Figure Global Gene Therapy Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Gene Therapy Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Gene Therapy Revenue Market Share Forecast by Type (2018-2025)
Table Global Gene Therapy Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Gene Therapy Sales (K Units) Forecast by Application (2018-2025)
Figure Global Gene Therapy Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Key Market Players
Beyond the listed companies, several additional players contribute significantly to the global gene therapy market:
- Sangamo Therapeutics (U.S.)
- Spark Therapeutics (U.S.)
- Dimension Therapeutics (U.S.)
- Avalanche Biotechnologies (U.S.)
- Celladon Corporation (U.S.)
- Vical Incorporated (U.S.)
- Advantagene Inc. (U.S.)
- Bluebird Bio (U.S.)
- Novartis AG (Switzerland) – CAR-T and gene therapy portfolio.
- Gilead Sciences/Kite Pharma (U.S.) – oncology-focused gene therapies.
- Pfizer Inc. (U.S.) – expanding pipeline in rare diseases.
- Roche/Genentech (Switzerland/U.S.) – oncology and ophthalmology gene therapies.
- UniQure N.V. (Netherlands) – pioneering AAV-based therapies.
- REGENXBIO Inc. (U.S.) – AAV vector technology.
- Orchard Therapeutics (U.K.) – rare disease therapies.
- Editas Medicine (U.S.) – CRISPR-based gene editing.
- CRISPR Therapeutics (Switzerland) – gene editing for blood disorders.
- Intellia Therapeutics (U.S.) – in vivo CRISPR therapies.
- Beam Therapeutics (U.S.) – base editing technologies.
Segments Analysis
By Product Type
- Ex vivo Gene Therapy – cells modified outside the body and reintroduced.
- In vivo Gene Therapy – direct delivery of genetic material into the patient.
By Application
- Cancer Diseases – CAR-T therapies, tumor suppressor gene delivery.
- Monogenic Diseases – hemophilia, muscular dystrophy, cystic fibrosis.
- Infectious Diseases – HIV, hepatitis, emerging viral infections.
- Cardiovascular Diseases – ischemic heart disease, heart failure.
- Others – ophthalmology, neurology, metabolic disorders.
Regional Analysis – Highlights
- North America: Largest market; strong presence of biotech firms, advanced healthcare infrastructure, and FDA approvals.
- Europe: Germany, U.K., and France lead; EMA supports rare disease therapies.
- Asia-Pacific: China and Japan expanding R&D; India and South Korea emerging with clinical trials.
- Latin America: Brazil and Argentina show growing adoption in oncology and rare disease treatments.
- Middle East & Africa: Early-stage adoption; demand linked to healthcare modernization and rare disease initiatives.